Thursday October 8, 2020 0 comments
ENGLEWOOD -- Paragon 28, Inc. announced the appointment of Steve Deitsch to the position of chief financial officer.
Deitsch assumes responsibility for finance, accounting, human resources, and information technology.
"We are pleased to have Steve on our team," said Albert DaCosta, Paragon 28, Inc.'s president and CEO.
"His financial and management expertise will help Paragon 28, Inc. put the tools in place to further grow the company. Our continued growth is essential to further our mission of advancing medical technology for foot and ankle surgeons and improving patient outcomes."
Deitsch brings extensive medical technology and healthcare executive experience to Paragon 28, Inc., including service as chief financial officer for BioScrip, Inc., Biomet, Inc.'s Spine Group, Lanx, Inc., Zimmer Americas, and Zimmer EMEA.
Under Deitsch’s financial leadership, BioScrip, a former publicly traded home healthcare services company with revenues in excess of $700 million, significantly increased its profitability and cash flows and completed a successful merger with Option Care in 2019 to form Option Care Health.
"Paragon 28 is the recognized leader in the foot and ankle orthopedic field, developing solutions to improve patients' lives,” said Deitsch.
“I welcome this opportunity to join such a special team and help grow the company in order to benefit the medical community."